3rd Quarter - Report

FOLEY & LARDNER LLP for NOVOCURE INC.

Firm
Client
Income
$150,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Medical devices

Foreign entity interest: Novocure Limited, identified on Form LD-1, owns 100% of Novocure, Inc.

LobbyistCovered position, as disclosed
MICHAEL E. CAPUANO Member of Congress, 1999-2019
MICHAEL CROSSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.